Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 BAY 63-2521 (Adempas/Riociguat) in adult deltaF508 homozygous cystic fibrosis patients
2013-004595-35Phase 2Terminated
- Sponsor
- Bayer
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing BAY63-2521 (Adempas/riociguat) tid with Placebo tid (2 arms). Started May 2014; status: terminated.
02
Drugs
riociguat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2013-004595-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004595-35.